Barclays’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-505,000
Closed -$2.37M 5149
2024
Q1
$2.37M Buy
505,000
+458,700
+991% +$1.76M ﹤0.01% 2430
2023
Q4
$227K Buy
+46,300
New +$227K ﹤0.01% 4359
2023
Q2
Sell
-106,300
Closed -$874K 4886
2023
Q1
$874K Sell
106,300
-114,900
-52% -$1.27M ﹤0.01% 2833
2022
Q4
$2.46M Buy
+221,200
New +$2.57M ﹤0.01% 2113
2020
Q2
Sell
-45,000
Closed -$778K 6011
2020
Q1
$778K Buy
+45,000
New +$941K ﹤0.01% 3215

Other funds holding MPT

Barclays's MPT Position: Q1 2026 in Review

Barclays increased its Medical Properties Trust (MPT) stake by 15% in Q1 2026, buying an estimated $164K and bringing the position to 241,844 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2693.

Barclays first reported a position in MPT in Q2 2013 and has held it in 52 quarters since. The position peaked at $50M in Q1 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Barclays held 241,844 shares of Medical Properties Trust worth $1.12M as of Q1 2026.
  • Barclays bought 31,490 Medical Properties Trust shares in Q1 2026, an estimated $164K.
  • Medical Properties Trust made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2693 holding.
  • Barclays first reported a position in Medical Properties Trust in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Medical Properties Trust position peaked at $50M in Q1 2022.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.